Investigational Three-Month TB Regimen Is Safe but Ineffective, NIH Study Finds

The first clinical trial of a three-month TB treatment regimen is closing enrollment because of a high rate of unfavorable outcomes with the investigational course of treatment.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news